<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045030"><TermName>pirfenidone</TermName><TermPronunciation>(peer-FEH-nih-done)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the prevention and treatment of scar tissue caused by radiation therapy. It belongs to the family of drugs called anti-inflammatory agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000728249" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pirfenidone&quot;" language="en" id="_3"/><MediaLink ref="CDR0000728248" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pirfenidona&quot;" language="es" id="_4"/><SpanishTermName>pirfenidona</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevenci√≥n y el tratamiento de las cicatrices causadas por la radioterapia. Pertenece al tipo de medicamentos llamados antiinflamatorios.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
